Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, has entered into a strategic distribution agreement with Promamec, a leading provider of medical devices in Morocco.
This collaboration demonstrates Zimmer Biomet’s commitment to expanding access to its advanced technologies and innovation solutions in the region.
“Our Mission is to alleviate pain and improve the quality of life for people in the region and worldwide. By partnering with Promamec, we are making it possible for more patients to access our advanced technologies, surgical robotics and implants,” said Farah Hamdan, Zimmer Biomet General Manager for Indirect Markets in Central & Eastern Europe, Middle East and Africa.
“We are thrilled to partner with Zimmer Biomet and deliver on Promamec’s mission to provide competitive and innovative medical solutions to healthcare professionals with the aim of improving the quality of our patient’s care,” said Naoufal Lahlou, CEO of Promamec. “This agreement strengthens and completes our ecosystem. We will leverage all our assets, tangible and intangible, at the service of this new partnership to offer our customers Zimmer Biomet’s portfolio.”
